Invention Grant
US08876791B2 Collateral pathway treatment using agent entrained by aspiration flow current
有权
通过吸入流动电流夹带的药物的抵押途径治疗
- Patent Title: Collateral pathway treatment using agent entrained by aspiration flow current
- Patent Title (中): 通过吸入流动电流夹带的药物的抵押途径治疗
-
Application No.: US12883039Application Date: 2010-09-15
-
Publication No.: US08876791B2Publication Date: 2014-11-04
- Inventor: Anthony Wondka , Peter Soltesz , John McCutcheon , Antony J. Fields
- Applicant: Anthony Wondka , Peter Soltesz , John McCutcheon , Antony J. Fields
- Applicant Address: US CA Redwood City
- Assignee: Pulmonx Corporation
- Current Assignee: Pulmonx Corporation
- Current Assignee Address: US CA Redwood City
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61M31/00
- IPC: A61M31/00 ; A61B17/12 ; A61M25/10 ; A61B17/22 ; A61B17/00
Abstract:
A method and system for increasing the flow resistance of collateral pathways in the lung by employing aspiration to establish an artificial convective flow current between compartments in the lung in order to entrain and deliver a clogging agent preferentially to the collateral pathways. The method may sometimes be performed after lung has been assessed for the presence of collateral pathways.
Public/Granted literature
- US20110220104A1 COLLATERAL PATHWAY TREATMENT USING AGENT ENTRAINED BY ASPIRATION FLOW CURRENT Public/Granted day:2011-09-15
Information query
